Literature DB >> 34537916

Understanding of sarcopenia: from definition to therapeutic strategies.

Jee Won Kim1, Ryuni Kim1, Hyerim Choi1, Sang-Jin Lee2, Gyu-Un Bae3.   

Abstract

Sarcopenia refers to the gradual loss of skeletal muscle mass and function along with aging and is a social burden due to growing healthcare cost associated with a super-aging society. Therefore, researchers have established guidelines and tests to diagnose sarcopenia. Several studies have been conducted actively to reveal the cause of sarcopenia and find an economic therapy to improve the quality of life in elderly individuals. Sarcopenia is caused by multiple factors such as reduced regenerative capacity, imbalance in protein turnover, alteration of fat and fibrotic composition in muscle, increased reactive oxygen species, dysfunction of mitochondria and increased inflammation. Based on these mechanisms, nonpharmacological and pharmacological strategies have been developed to prevent and treat sarcopenia. Although several studies are currently in progress, no treatment is available yet. This review presents the definition of sarcopenia and summarizes recent understanding on the detailed mechanisms, diagnostic criteria, and strategies for prevention and treatment.
© 2021. The Pharmaceutical Society of Korea.

Entities:  

Keywords:  Aging; Protein turnover; Sarcopenia; Satellite cell; Skeletal muscle

Mesh:

Substances:

Year:  2021        PMID: 34537916     DOI: 10.1007/s12272-021-01349-z

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  144 in total

Review 1.  Chaperone-mediated autophagy in protein quality control.

Authors:  Esperanza Arias; Ana Maria Cuervo
Journal:  Curr Opin Cell Biol       Date:  2010-11-18       Impact factor: 8.382

2.  Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men.

Authors:  Ross A Atkinson; U Srinivas-Shankar; Stephen A Roberts; Martin J Connolly; Judith E Adams; Jackie A Oldham; Frederick C W Wu; Olivier R Seynnes; Claire E H Stewart; Constantinos N Maganaris; Marco V Narici
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-02       Impact factor: 6.053

Review 3.  Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease.

Authors:  Albert E Almada; Amy J Wagers
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-09       Impact factor: 94.444

4.  HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy.

Authors:  Adam W Beharry; Pooja B Sandesara; Brandon M Roberts; Leonardo F Ferreira; Sarah M Senf; Andrew R Judge
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

5.  Cdo binds Abl to promote p38alpha/beta mitogen-activated protein kinase activity and myogenic differentiation.

Authors:  Gyu-Un Bae; Bok-Geon Kim; Hye-Jin Lee; Ji-Eun Oh; Su-Jae Lee; Wei Zhang; Robert S Krauss; Jong-Sun Kang
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

Review 6.  Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.

Authors:  Sumbul Ali; Jose M Garcia
Journal:  Gerontology       Date:  2014-04-08       Impact factor: 5.140

7.  Mitochondrial impairment induced by postnatal ActRIIB blockade does not alter function and energy status in exercising mouse glycolytic muscle in vivo.

Authors:  Nelly Béchir; Émilie Pecchi; Karima Relizani; Christophe Vilmen; Yann Le Fur; Monique Bernard; Helge Amthor; David Bendahan; Benoît Giannesini
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-02       Impact factor: 4.310

Review 8.  Epigenetic control of adult stem cell function.

Authors:  Alexandra Avgustinova; Salvador Aznar Benitah
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-13       Impact factor: 94.444

9.  Reactive oxygen species in skeletal muscle signaling.

Authors:  Elena Barbieri; Piero Sestili
Journal:  J Signal Transduct       Date:  2011-12-05

10.  Association between handgrip strength, balance, and knee flexion/extension strength in older adults.

Authors:  Angelica Castilho Alonso; Samia Maria Ribeiro; Natália Mariana Silva Luna; Mark D Peterson; Danilo Sales Bocalini; Marcos Maurício Serra; Guilherme Carlos Brech; Julia Maria D'Andréa Greve; Luiz Eugênio Garcez-Leme
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

View more
  6 in total

Review 1.  Sarcopenia and Mortality Risk of Patients with Sepsis: A Meta-Analysis.

Authors:  Wei Liu; Chenghuan Hu; Shuangping Zhao
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

2.  DXA-Derived Indices in the Characterisation of Sarcopenia.

Authors:  Natascha Schweighofer; Caterina Colantonio; Christoph W Haudum; Barbara Hutz; Ewald Kolesnik; Ines Mursic; Stefan Pilz; Albrecht Schmidt; Vanessa Stadlbauer; Andreas Zirlik; Thomas R Pieber; Nicolas Verheyen; Barbara Obermayer-Pietsch
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

Review 3.  Exercise and Nutrition Impact on Osteoporosis and Sarcopenia-The Incidence of Osteosarcopenia: A Narrative Review.

Authors:  Sousana K Papadopoulou; Konstantinos Papadimitriou; Gavriela Voulgaridou; Evridiki Georgaki; Eudoxia Tsotidou; Olga Zantidou; Dimitrios Papandreou
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

Review 4.  Immunometabolism of macrophages regulates skeletal muscle regeneration.

Authors:  Yu-Fan Chen; Chien-Wei Lee; Hao-Hsiang Wu; Wei-Ting Lin; Oscar K Lee
Journal:  Front Cell Dev Biol       Date:  2022-09-06

Review 5.  Bibliometric Analysis of the Knowledge Base and Future Trends on Sarcopenia from 1999-2021.

Authors:  Yao Xiao; Ziheng Deng; Hangjing Tan; Tiejian Jiang; Zhiheng Chen
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

Review 6.  Skeletal muscle oxidative stress and inflammation in aging: Focus on antioxidant and anti-inflammatory therapy.

Authors:  Mingming Chen; Yiyi Wang; Shoulong Deng; Zhengxing Lian; Kun Yu
Journal:  Front Cell Dev Biol       Date:  2022-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.